PhilArchive
open access
The Promise and Perils of Biotech in Personalised Healthcare. Can New Regulatory Pathways Protect the Vulnerable?
The paper discusses some of the implications of regulatory innovation in the area of advanced biological therapies and personalised medicine. Benefits, risks and trade-offs are highlighted.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Les nouvelles biotechnologies en questions. Préface de Jean Audouze. Paris, Éditions Salvator , 2013, 127 p.#735402
- Beyond Therapy: Biotechnology and the Pursuit of Happiness, by the President’s Council on Bioethics#704055
- 2. Ethical concerns in the implementation of personalized medicine – the bedrock of current and future policy#1815
- The Other Value in the Debate over Genetically Modified Organisms#749090
- Ethical qualms about genetic prognosis#720184
Record · ID 719105
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive